West Pharmaceutical Services Inc (WST)

Debt-to-assets ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total assets US$ in thousands 3,643,400 3,675,100 3,489,400 3,602,300 3,829,500 3,754,700 3,669,600 3,723,600 3,616,800 3,316,800 3,361,700 3,294,700 3,313,800 3,142,600 2,933,500 2,739,700 2,793,800 2,582,800 2,392,300 2,246,500
Debt-to-assets ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $3,643,400K
= 0.00

The debt-to-assets ratio for West Pharmaceutical Services Inc has consistently remained at 0.00 throughout the reporting periods from March 31, 2020, to December 31, 2024. This indicates that the company has not used debt to finance its operations and investments during these periods. A debt-to-assets ratio of 0.00 suggests that the company's assets are completely financed by equity rather than debt, which can be seen as a positive indicator of financial stability and solvency. It implies that the company has a strong financial position and does not rely heavily on borrowing to support its operations or expansion activities.


Peer comparison

Dec 31, 2024

Company name
Symbol
Debt-to-assets ratio
West Pharmaceutical Services Inc
WST
0.00
Carlisle Companies Incorporated
CSL
0.00